| 000 | 00000nam##2200000za#4500 |
| 001 | 9.575951 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624184917 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|2013||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aXC16-1/1-411-11E-PDF |
|---|
| 110 | 1 |aCanada. |bParliament. |bHouse of Commons. |bStanding Committee on Public Accounts. |
|---|
| 245 | 10|aChapter 4, regulating pharmaceutical drugs - Health Canada, of the Fall 2011 report of the Auditor General of Canada / |h[electronic resource]|cDavid Christopherson, Chair. |
|---|
| 260 | |aOttawa - Ontario : |bHouse of Commons. |cFebruary 2013. |
|---|
| 300 | |a34p.|btables |
|---|
| 490 | 1 |aReport of the Standing Committee on Public Accounts|v41st Parliament, 1st Session, 11th report |
|---|
| 500 | |aOriginal published on: 2013/02/11; published on: 2013/02/14; published on: 2013/02/15; published On: 2013/04/10 |
|---|
| 590 | |a13-07|b2013-02-15 |
|---|
| 590 | |a13-08|b2013-02-22 |
|---|
| 590 | |a13-15|b2013-04-12 |
|---|
| 775 | 08|tLe chapitre 4, La réglementation des médicaments - Santé Canada, du rapport d'automne 2011 du vérificateur général du Canada / |w(CaOODSP)9.605325 |
|---|
| 830 | #0|aReport of the Standing Committee on Public Accounts ;|v41st Parliament, 1st Session, 11th report|w(CaOODSP)9.505304 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s424 KB|uhttps://publications.gc.ca/collections/collection_2013/parl/XC16-1-1-411-11-eng.pdf|y41st Parliament, 1st Session, 11th report |
|---|